NCT00004576View on ClinicalTrials.gov

Study of LY300164 for the Treatment of Parkinson's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 29, 2000

Study Completion Date

August 31, 2000

Conditions
DyskinesiasParkinson Disease
Interventions
DRUG

LY300164

Trial Locations (1)

20892

National Institute of Neurological Disorders and Stroke (NINDS), Bethesda

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT00004576 - Study of LY300164 for the Treatment of Parkinson's Disease | Biotech Hunter | Biotech Hunter